iiCON at the heart of infectious disease research This year, a new AI robotic laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases was announced in Liverpool UK. The £20 million ($26.4 million) Liverpool Accelerate Laboratory was developed through the Infection Innovation Consortium: iiCON – an initiative dedicated to advancing pioneering infection R&D through collaboration between […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!